Tags |
|
|
Links |
|
|
Digg It - Indicators - From a Personal Source
An indicator is statistical information about a certain activity.
Statistical information is used to manage and control
Statistical information is used to manage and control
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
activities. Organizations need information about activities that take place and which cost money and generate income.
E
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
conomic indicators summarize similar information about business activities on a large economic scale.
The unemployment r
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ate is an example of such an indicator. An unemployment rate that increases could mean (indicate) that the economy is sow
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ing down.
These indications are useful to prepare actions and to take new decisions. The investment area is therefore on
These indications are useful to prepare actions and to take new decisions. The investment area is therefore on
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
e place where people use statistical information and where indicators come in handy.
Another benefit from these indicat
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ors is that the information is transparent and available to the public, mostly at the same time these figures are publish
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ed.
There are also other kinds of indicators that are as least as useful and they have a private scope rather than a pub
There are also other kinds of indicators that are as least as useful and they have a private scope rather than a pub
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
lic availability. These indicators are derived from a private information gathering process.
Think that you are to inves
Think that you are to inves
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
t in a company, but you wouldn’t know what. A simple rule is to invest in things that area near. Examples are the electri
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
city company that delivers current, the oil company that delivers your motor fuel, the telco that offers ADSL, the superm
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
arket for the weekly groceries, the bank for your financial transactions, etc, etc.
There is a lot of information availa
There is a lot of information availa
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ble from these companies in newspapers, but you can derive your own indicators from contact with these companies. From yo
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ur insurer you can check how they respond to questions, how fast, how polite, how accurate, in fact you get easily an ove
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
rview of how they operate. This is your first private indicator from this company. You cannot ship on this indicator alon
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
e but you should match it with other information you receive from the official agencies.
The personal indicator is howev
The personal indicator is howev
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
er often quite a good sensor of how the company is doing. If you have personally experienced how a certain company handle
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
s the closing of a contract and checked this with other people, than this information is quite useful in analyzing the co
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
mpany.
The advantage of this personal indicator is that it is a first source of nearly insight information. The disadvan
The advantage of this personal indicator is that it is a first source of nearly insight information. The disadvan
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
tage is that it is subjective and you could be wrong. You should always check it with other indicators.
© 2007 Hans Bool
© 2007 Hans Bool
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/89465/diggit-Indicators--From-a-Personal-Source.html">Indicators - From a Personal Source</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/89465/diggit-Indicators--From-a-Personal-Source.html]Indicators - From a Personal Source[/url]
Related Articles:
Step One To Creating An Effective Direct Response Piece
Medical Billing - GD0 Record Fields 51 Through 56
Small Business Marketing Strategy - Consistent Brand Building
Bookmark it:
|